Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Drugs for Osteoarthritis Pain market report explains the definition, types, applications, major countries, and major players of the Drugs for Osteoarthritis Pain market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Johnson & Johnson
Novartis
GlaxoSmithKline
Pfizer
Tide Pharmaceutical
Abbott
Mylan
Almatica Pharma
Horizon Pharma
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Sanofi
Bayer
TEVA
Astellas Pharma
Eli Lilly
Daiichi Sankyo
By Type:
Oral
Injection
External
By End-User:
Medical Care
Personal Care
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Drugs for Osteoarthritis Pain Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Drugs for Osteoarthritis Pain Outlook to 2028- Original Forecasts
-
2.2 Drugs for Osteoarthritis Pain Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Drugs for Osteoarthritis Pain Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Drugs for Osteoarthritis Pain Market- Recent Developments
-
6.1 Drugs for Osteoarthritis Pain Market News and Developments
-
6.2 Drugs for Osteoarthritis Pain Market Deals Landscape
7 Drugs for Osteoarthritis Pain Raw Materials and Cost Structure Analysis
-
7.1 Drugs for Osteoarthritis Pain Key Raw Materials
-
7.2 Drugs for Osteoarthritis Pain Price Trend of Key Raw Materials
-
7.3 Drugs for Osteoarthritis Pain Key Suppliers of Raw Materials
-
7.4 Drugs for Osteoarthritis Pain Market Concentration Rate of Raw Materials
-
7.5 Drugs for Osteoarthritis Pain Cost Structure Analysis
-
7.5.1 Drugs for Osteoarthritis Pain Raw Materials Analysis
-
7.5.2 Drugs for Osteoarthritis Pain Labor Cost Analysis
-
7.5.3 Drugs for Osteoarthritis Pain Manufacturing Expenses Analysis
8 Global Drugs for Osteoarthritis Pain Import and Export Analysis (Top 10 Countries)
-
8.1 Global Drugs for Osteoarthritis Pain Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Drugs for Osteoarthritis Pain Export by Region (Top 10 Countries) (2017-2028)
9 Global Drugs for Osteoarthritis Pain Market Outlook by Types and Applications to 2022
-
9.1 Global Drugs for Osteoarthritis Pain Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Injection Consumption and Growth Rate (2017-2022)
-
9.1.3 Global External Consumption and Growth Rate (2017-2022)
-
9.2 Global Drugs for Osteoarthritis Pain Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Medical Care Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Personal Care Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Drugs for Osteoarthritis Pain Market Analysis and Outlook till 2022
-
10.1 Global Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.2.2 Canada Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.2.3 Mexico Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.2 UK Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.3 Spain Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.4 Belgium Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.5 France Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.6 Italy Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.7 Denmark Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.8 Finland Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.9 Norway Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.10 Sweden Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.11 Poland Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.12 Russia Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.3.13 Turkey Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.4.2 Japan Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.4.3 India Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.4.4 South Korea Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.4.5 Pakistan Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.4.6 Bangladesh Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.4.7 Indonesia Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.4.8 Thailand Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.4.9 Singapore Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.4.10 Malaysia Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.4.11 Philippines Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.4.12 Vietnam Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.5.2 Colombia Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.5.3 Chile Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.5.4 Argentina Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.5.5 Venezuela Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.5.6 Peru Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.5.7 Puerto Rico Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.5.8 Ecuador Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.6.2 Kuwait Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.6.3 Oman Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.6.4 Qatar Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.6.5 Saudi Arabia Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.6.6 United Arab Emirates Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.7.2 South Africa Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.7.3 Egypt Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.7.4 Algeria Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Drugs for Osteoarthritis Pain Consumption (2017-2022)
-
10.8.2 New Zealand Drugs for Osteoarthritis Pain Consumption (2017-2022)
11 Global Drugs for Osteoarthritis Pain Competitive Analysis
-
11.1 Johnson & Johnson
-
11.1.1 Johnson & Johnson Company Details
-
11.1.2 Johnson & Johnson Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Johnson & Johnson Drugs for Osteoarthritis Pain Main Business and Markets Served
-
11.1.4 Johnson & Johnson Drugs for Osteoarthritis Pain Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Novartis
-
11.2.1 Novartis Company Details
-
11.2.2 Novartis Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Novartis Drugs for Osteoarthritis Pain Main Business and Markets Served
-
11.2.4 Novartis Drugs for Osteoarthritis Pain Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 GlaxoSmithKline
-
11.3.1 GlaxoSmithKline Company Details
-
11.3.2 GlaxoSmithKline Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Main Business and Markets Served
-
11.3.4 GlaxoSmithKline Drugs for Osteoarthritis Pain Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Pfizer
-
11.4.1 Pfizer Company Details
-
11.4.2 Pfizer Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Pfizer Drugs for Osteoarthritis Pain Main Business and Markets Served
-
11.4.4 Pfizer Drugs for Osteoarthritis Pain Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Tide Pharmaceutical
-
11.5.1 Tide Pharmaceutical Company Details
-
11.5.2 Tide Pharmaceutical Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Main Business and Markets Served
-
11.5.4 Tide Pharmaceutical Drugs for Osteoarthritis Pain Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Abbott
-
11.6.1 Abbott Company Details
-
11.6.2 Abbott Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Abbott Drugs for Osteoarthritis Pain Main Business and Markets Served
-
11.6.4 Abbott Drugs for Osteoarthritis Pain Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Mylan
-
11.7.1 Mylan Company Details
-
11.7.2 Mylan Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Mylan Drugs for Osteoarthritis Pain Main Business and Markets Served
-
11.7.4 Mylan Drugs for Osteoarthritis Pain Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Almatica Pharma
-
11.8.1 Almatica Pharma Company Details
-
11.8.2 Almatica Pharma Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Almatica Pharma Drugs for Osteoarthritis Pain Main Business and Markets Served
-
11.8.4 Almatica Pharma Drugs for Osteoarthritis Pain Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Horizon Pharma
-
11.9.1 Horizon Pharma Company Details
-
11.9.2 Horizon Pharma Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Horizon Pharma Drugs for Osteoarthritis Pain Main Business and Markets Served
-
11.9.4 Horizon Pharma Drugs for Osteoarthritis Pain Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Iroko Pharmaceuticals
-
11.10.1 Iroko Pharmaceuticals Company Details
-
11.10.2 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Main Business and Markets Served
-
11.10.4 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Hengrui Pharmaceutical
-
11.11.1 Hengrui Pharmaceutical Company Details
-
11.11.2 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Main Business and Markets Served
-
11.11.4 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Abiogen Pharma
-
11.12.1 Abiogen Pharma Company Details
-
11.12.2 Abiogen Pharma Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Abiogen Pharma Drugs for Osteoarthritis Pain Main Business and Markets Served
-
11.12.4 Abiogen Pharma Drugs for Osteoarthritis Pain Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Sanofi
-
11.13.1 Sanofi Company Details
-
11.13.2 Sanofi Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Sanofi Drugs for Osteoarthritis Pain Main Business and Markets Served
-
11.13.4 Sanofi Drugs for Osteoarthritis Pain Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Bayer
-
11.14.1 Bayer Company Details
-
11.14.2 Bayer Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Bayer Drugs for Osteoarthritis Pain Main Business and Markets Served
-
11.14.4 Bayer Drugs for Osteoarthritis Pain Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 TEVA
-
11.15.1 TEVA Company Details
-
11.15.2 TEVA Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 TEVA Drugs for Osteoarthritis Pain Main Business and Markets Served
-
11.15.4 TEVA Drugs for Osteoarthritis Pain Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Astellas Pharma
-
11.16.1 Astellas Pharma Company Details
-
11.16.2 Astellas Pharma Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Astellas Pharma Drugs for Osteoarthritis Pain Main Business and Markets Served
-
11.16.4 Astellas Pharma Drugs for Osteoarthritis Pain Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Eli Lilly
-
11.17.1 Eli Lilly Company Details
-
11.17.2 Eli Lilly Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Eli Lilly Drugs for Osteoarthritis Pain Main Business and Markets Served
-
11.17.4 Eli Lilly Drugs for Osteoarthritis Pain Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Daiichi Sankyo
-
11.18.1 Daiichi Sankyo Company Details
-
11.18.2 Daiichi Sankyo Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Main Business and Markets Served
-
11.18.4 Daiichi Sankyo Drugs for Osteoarthritis Pain Product Portfolio
-
11.18.5 Recent Research and Development Strategies
12 Global Drugs for Osteoarthritis Pain Market Outlook by Types and Applications to 2028
-
12.1 Global Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global External Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Medical Care Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Personal Care Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Drugs for Osteoarthritis Pain Market Analysis and Outlook to 2028
-
13.1 Global Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.2.2 Canada Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.2.3 Mexico Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.2 UK Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.3 Spain Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.4 Belgium Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.5 France Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.6 Italy Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.7 Denmark Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.8 Finland Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.9 Norway Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.10 Sweden Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.11 Poland Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.12 Russia Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.3.13 Turkey Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4.2 Japan Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4.3 India Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4.4 South Korea Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4.8 Thailand Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4.9 Singapore Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4.11 Philippines Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.5.2 Colombia Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.5.3 Chile Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.5.4 Argentina Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.5.6 Peru Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.6.3 Oman Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.6.4 Qatar Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.7.2 South Africa Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.7.3 Egypt Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.7.4 Algeria Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Drugs for Osteoarthritis Pain Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Drugs for Osteoarthritis Pain
-
Figure of Drugs for Osteoarthritis Pain Picture
-
Table Global Drugs for Osteoarthritis Pain Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Drugs for Osteoarthritis Pain Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global External Consumption and Growth Rate (2017-2022)
-
Figure Global Medical Care Consumption and Growth Rate (2017-2022)
-
Figure Global Personal Care Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs for Osteoarthritis Pain Consumption by Country (2017-2022)
-
Table North America Drugs for Osteoarthritis Pain Consumption by Country (2017-2022)
-
Figure United States Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Canada Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Mexico Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Table Europe Drugs for Osteoarthritis Pain Consumption by Country (2017-2022)
-
Figure Germany Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure UK Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Spain Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Belgium Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure France Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Italy Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Denmark Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Finland Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Norway Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Sweden Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Poland Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Russia Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Turkey Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Table APAC Drugs for Osteoarthritis Pain Consumption by Country (2017-2022)
-
Figure China Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Japan Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure India Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure South Korea Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Thailand Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Singapore Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Philippines Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Table South America Drugs for Osteoarthritis Pain Consumption by Country (2017-2022)
-
Figure Brazil Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Colombia Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Chile Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Argentina Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Peru Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Table GCC Drugs for Osteoarthritis Pain Consumption by Country (2017-2022)
-
Figure Bahrain Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Oman Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Qatar Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Table Africa Drugs for Osteoarthritis Pain Consumption by Country (2017-2022)
-
Figure Nigeria Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure South Africa Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Egypt Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure Algeria Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Table Oceania Drugs for Osteoarthritis Pain Consumption by Country (2017-2022)
-
Figure Australia Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Drugs for Osteoarthritis Pain Consumption and Growth Rate (2017-2022)
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Drugs for Osteoarthritis Pain Main Business and Markets Served
-
Table Johnson & Johnson Drugs for Osteoarthritis Pain Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Drugs for Osteoarthritis Pain Main Business and Markets Served
-
Table Novartis Drugs for Osteoarthritis Pain Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Drugs for Osteoarthritis Pain Main Business and Markets Served
-
Table GlaxoSmithKline Drugs for Osteoarthritis Pain Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Drugs for Osteoarthritis Pain Main Business and Markets Served
-
Table Pfizer Drugs for Osteoarthritis Pain Product Portfolio
-
Table Tide Pharmaceutical Company Details
-
Table Tide Pharmaceutical Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tide Pharmaceutical Drugs for Osteoarthritis Pain Main Business and Markets Served
-
Table Tide Pharmaceutical Drugs for Osteoarthritis Pain Product Portfolio
-
Table Abbott Company Details
-
Table Abbott Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Drugs for Osteoarthritis Pain Main Business and Markets Served
-
Table Abbott Drugs for Osteoarthritis Pain Product Portfolio
-
Table Mylan Company Details
-
Table Mylan Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Drugs for Osteoarthritis Pain Main Business and Markets Served
-
Table Mylan Drugs for Osteoarthritis Pain Product Portfolio
-
Table Almatica Pharma Company Details
-
Table Almatica Pharma Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Almatica Pharma Drugs for Osteoarthritis Pain Main Business and Markets Served
-
Table Almatica Pharma Drugs for Osteoarthritis Pain Product Portfolio
-
Table Horizon Pharma Company Details
-
Table Horizon Pharma Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Horizon Pharma Drugs for Osteoarthritis Pain Main Business and Markets Served
-
Table Horizon Pharma Drugs for Osteoarthritis Pain Product Portfolio
-
Table Iroko Pharmaceuticals Company Details
-
Table Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Main Business and Markets Served
-
Table Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product Portfolio
-
Table Hengrui Pharmaceutical Company Details
-
Table Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Main Business and Markets Served
-
Table Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product Portfolio
-
Table Abiogen Pharma Company Details
-
Table Abiogen Pharma Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abiogen Pharma Drugs for Osteoarthritis Pain Main Business and Markets Served
-
Table Abiogen Pharma Drugs for Osteoarthritis Pain Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Drugs for Osteoarthritis Pain Main Business and Markets Served
-
Table Sanofi Drugs for Osteoarthritis Pain Product Portfolio
-
Table Bayer Company Details
-
Table Bayer Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Drugs for Osteoarthritis Pain Main Business and Markets Served
-
Table Bayer Drugs for Osteoarthritis Pain Product Portfolio
-
Table TEVA Company Details
-
Table TEVA Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table TEVA Drugs for Osteoarthritis Pain Main Business and Markets Served
-
Table TEVA Drugs for Osteoarthritis Pain Product Portfolio
-
Table Astellas Pharma Company Details
-
Table Astellas Pharma Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Drugs for Osteoarthritis Pain Main Business and Markets Served
-
Table Astellas Pharma Drugs for Osteoarthritis Pain Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Drugs for Osteoarthritis Pain Main Business and Markets Served
-
Table Eli Lilly Drugs for Osteoarthritis Pain Product Portfolio
-
Table Daiichi Sankyo Company Details
-
Table Daiichi Sankyo Drugs for Osteoarthritis Pain Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Drugs for Osteoarthritis Pain Main Business and Markets Served
-
Table Daiichi Sankyo Drugs for Osteoarthritis Pain Product Portfolio
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global External Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medical Care Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Personal Care Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugs for Osteoarthritis Pain Consumption Forecast by Country (2022-2028)
-
Table North America Drugs for Osteoarthritis Pain Consumption Forecast by Country (2022-2028)
-
Figure United States Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Drugs for Osteoarthritis Pain Consumption Forecast by Country (2022-2028)
-
Figure Germany Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Drugs for Osteoarthritis Pain Consumption Forecast by Country (2022-2028)
-
Figure China Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Drugs for Osteoarthritis Pain Consumption Forecast by Country (2022-2028)
-
Figure Brazil Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Drugs for Osteoarthritis Pain Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Drugs for Osteoarthritis Pain Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Drugs for Osteoarthritis Pain Consumption Forecast by Country (2022-2028)
-
Figure Australia Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Drugs for Osteoarthritis Pain Consumption Forecast and Growth Rate (2022-2028)
-
